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1. Introduction
  Several epidemiological studies have shown that a 
diet rich in vegetables and fruits might protect against 
cancer by mechanisms that have not been well defined 
yet. In recent years, naturally occurring plant products 
have been getting increased attention for the intervention 
of malignant invasive progression in the late stage of 
neoplastic diseases[1, 2]. On the basis of this idea, certain 
foods including many vegetables, fruits, and grains, as well 
as phytochemicals of diversified pharmacological efficacies 
have been shown to offer a significant protection against 
various cancers[3-5]. Furthermore, there is an increased 
focus on providing scientific basis to use these agents in the 
prevention strategy for people with a high risk for cancers. 
  Tephrosia purpurea (TP) L. (Fabaceae), commonly known 
as “Sharapunkha” in Sanskrit, is a copiously branched, 
sub-erect, herbaceous perennial plant, which occurs 
through out the Indian[6]. Whole plant has been used to 
cure tumors, ulcers, leprosy, allergic and inflammatory 
conditions such as rheumatism, asthma and bronchitis[7]. 
The aqueous extract of TP seeds has shown significant 
in vivo hypoglycemic activity in diabetic rabbits[8]. The 
flavanoids isolated from the plant has been reported to have 
antimicrobial activity[9]. It has also been reported to acquire 
hepatoprotective, mast cell stabilizing and erythrocyte 
membrane integrity enhancing effect in various animal 
models[10-11]. Phytochemical investigations on TP have 
revealed the presence of various phytoactive constituents 
such as glycosides, rotenoids, isoflavones, flavanones, 
chalcones, flavanols, flavones and sterols[12].
  Ficus religiosa (FR) L. (Moraceae) commonly known 
as ‘Peepal’ is a variety of fig and sacred tree native to 
India. It is reported to have numerous therapeutic uses in 
folkmedicine viz.: leaf juice has been used for the treatment 
of asthma, cough, sexual disorders, diarrhea, haematuria, 
ear-ache and toothache, migraine, eye troubles, gastric 
problems and scabies; leaf decoction has been used as an 
analgesic for toothache; fruits for the treatment of asthma, 
other respiratory disorders and scabies; stem bark is used 
in gonorrhea, bleeding, paralysis, diabetes, diarrhea, 
bone fracture, antiseptic, astringent and antidote[13]. In 
Ayurveda it is claimed that FR possesses anticonvulsant 
activity[14], acetyl cholinesterase inhibitory activity[15] and 
antianxiety activity[16]. Fruits of this plant contain numerous 
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amino acids whereas figs of this plant has been reported to 
contain highest amount of serotonin[5-HT] as compare to 
figs of other Ficus species[17]. Phytochemical investigations 
on FR have revealed the presence of various phytoactive 
constituents such as glycosides, sterols, tannins, amino 
acids, campesterol, isofucosterol, stigmasterol and lupeol. 
Leaf extract of FR had been shown to contain high amounts 
of tannins, phenols, triterpenoids, glucosides and sterols[18-20].
 
2. Material and methods
2.1. Plant material 
  The leaves of TP and FR were collected from the local 
region in July, 2008. The plant material was identified and 
authenticated by Prof. P. G. Diwakar, Botanical survey of 
India, Pune (Voucher No. BSI/WC/Tech/08/340). 
2.2. Preparation of TP fractions 
  The extraction was carried out using pet ether initially, 
then it was allowed to evaporate slowly in shallow dish 
and resinous mass was discarded. The remaining material 
was further fractionated into acetone soluble and acetone 
insoluble portions. These two portions were dissolved 
in benzene and subjected to column chromatographic 
separation as detailed below. 
  (1) Chromatographic separation of acetone soluble and 
insoluble part 
  For column chromatography Silica gel c was first activated 
at 150 曟 for 3 h in an oven. After cooling, slurry was 
prepared in benzene, it was poured in glass column and set 
aside for 2 h. The residue of pet ether extract was dissolved 
in minimum volume of benzene and it was mixed thoroughly 
with silica gel. It was air dried and charged into the column. 
The elution was carried out first with benzene (TPI) and 
successively with ethyl acetate (TPII). The solvents were 
changed when portion of eluent showed absence of residue. 
The separation of acetone insoluble part was carried out 
as described above with benzene (TPIII) followed by ethyl 
acetate. 
  (2)  Preparation of fractions of alcoholic extract 
The dried alcoholic extract was separated into water soluble 
and water insoluble portion (TPIV) using minimum quantity 
of distilled water. Only about 10% extract was soluble in 
water, which was vigorously shaken repeatedly with small 
volumes of ethyl acetate (TPV) till the ethyl acetate layer 
becomes colorless.
2.3. Preparation of FR fractions 
  The extraction was carried out using pet ether followed 
by alcohol, then it was allowed to evaporate slowly in 
shallow dish and resinous mass was discarded. For column 
chromatography neutral alumina was first activated at 150 曟
for 3 h in an oven. After cooling, slurry was prepared in 
benzene, it was poured in glass column and set aside 
for 2 h. The residue of pet ether extract was dissolved in 
minimum volume of benzene and it was mixed thoroughly 
with neutral alumina. It was air dried and charged into 
the column. The elution was carried out first with benzene 
(FRI) and successively eluted with ethyl acetate (FRII). The 
dried alcoholic extract was separated into water soluble and 
water insoluble portion Water soluble portion was shaken 
vigorously with methanol yielded a gelatinous precipitate 
(FRIII). The water insoluble part was dissolved in minimum 
volume of absolute alcohol and column chromatography was 
carried out with benzene (FRIV) and ethyl acetate (FRV).
2.4. Trypan blue exclusion test of cell viability
  The dye trypan blue exclusion test is used to determine 
the number of viable cells present in a cell suspension. It 
is based on the principle that live cells possess intact cell 
membranes that exclude certain dyes, such as trypan blue, 
Eosin, or propidium, whereas dead cells do not. In this test, 
a cell suspension is simply mixed with dye and then visually 
examined to determine whether cells take up or exclude 
dye. In the protocol presented here, a viable cell will have 
a clear cytoplasm whereas a nonviable cell will have a blue 
cytoplasm. In brief, an aliquot of MCF -7 cell suspension 
was centrifuged for 5 min at 100 伊 g and supernatant was 
discarded. The pellet formed thus resuspended in 1 mL
of PBS which serves as cell suspension. 1 part of 0.4% 
trypan blue was mixed with 1 part cell suspension and 
supplemented with TPI, TPIII, FRI and FRIII fractions(0, 20, 
40, 60, 80, 100, 120, 140, 160, 180 and 200 毺g/mL)  allowed 
to incubate for 3 min at room temperature. A drop of trypan 
blue/cell mixture was applied to a hemacytometer and 
placed on the stage of a binocular microscope and focus on 
the cells. The unstained (viable) and stained (nonviable) 
cells were counted separately to obtain the total number of 
viable cells per ml of aliquot[21].
  Viability can be calculated with the formula 
% Viability = 
Total number of living cells
Total number of cells
伊100  
3. Results
 The Figure 1 and 2  showed that sharp inhibition in the 
cancer cell lines while neither decrease nor increase in the 
log cell count. It can be interpreted as the drug scaffold 
having inhibitory activity against the breast cancer cell lines 
but in case of normal cell line drug was ineffective. The drug 
neither allowed the cell growth nor killed the existing cell. 
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The IC50 value for TPI was found to be152.4 毺M, whereas the 
IC50 value for TPIII was found to be 158.71 毺M.
  The graphs 3 and 4 showed inhibition in the cancer cell 
lines while it shows no decrease no increase in the log cell 
count. This shows the signs of cytotoxicity with the normal 
epithelial cell. The IC50 value for FRI was found to be 160.3 毺M,
whereas the IC50 value for FRIII was found to be 222.7 毺M.
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Figure 1. Effect of varying concentration of TP I on trypan blue 
exclusion test of cell viability in MCF 7 cell lines.
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Figure 2. Effect of varying concentration of TP III on trypan blue 
exclusion test of cell viability in MCF 7 cell lines.
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Figure 3. Effect of varying concentration of FRI on trypan blue 
exclusion test of cell viability in MCF 7 cell lines.
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Figure 4. Effect of varying concentration of FRIII on trypan blue 
exclusion test of cell viability in MCF 7 cell lines.
4. Discussion
  Cancer is a growing health problem around the world. 
Natural products have long been used to prevent and treat 
many diseases, including cancer and thus they are good 
candidates for the development of anti-cancer drugs. The 
large population use ayurvedic medicine worldwide, there 
is urgent need for additional, carefully conducted, high-
quality intensive research to evaluate its efficacy and to 
develop this discipline to meet ever-new challenges of 
modern medicine in the field cancer research. Different 
in vivo and in vitro screening models are available for 
anticancer activity. In the present study, we used human 
breast cancer cell line such as MCF-7 cells. MCF-7 cells, 
which are estrogen receptor (ER)-dependent and carries 
the wild type tumour suppressor p53 gene[22] are tested 
by using trypan blue exclusion method which is based on 
decrease in viable tumor cell count and increased non-
viable tumor cell count. The proposed study revealed that 
the fractions obtained from both plants were effective in 
attenuating the viable tumor cell count.  For both fractions 
of TP i.e. TP I and TP III employed in this study, viable tumor 
cell count decreased in dose dependant manner and more 
predominantly at concentration of 200 毺g/mL where each 
of these fractions inhibit all the viable tumor MCF-7 cell. 
Similarly, fractions obtained from Ficus religiosa named 
FR I and FR III also inhibits the viable cell count but not 
as effective as that of TP I and TP III. The concentration at 
which FR I and FR III inhibit the viable tumor cell count was 
beyond 200 毺g/mL which reveals that TP fractions are more 
potent in inhibiting the MCF-7 cells.  
  Previous studies in our laboratory showed that the extracts 
of TP are rich in flavonoid content and the cytotoxic might 
be due to the presence of flavonoids in the fractions utilized 
in this study as flavonoids have been shown to possess 
antimutagenic and antimalignant effect[23-24].
  Moreover, flavonoids have a chemopreventive role in 
cancer through their effects on signal transduction in cell 
proliferation and angiogenesis[25-27].
  Treatment with FR fractions showed cytotoxic activity 
which was less potent as compare to TP. However this 
activity may be due to the presence of phenolic contents 
in the fractions. It was reported that along with antioxidant 
activity, this group of compounds also posses a wide 
variety of biological functions which are mainly related 
to modulation of carcinogenesis. Various in vitro and 
in vivo systems have been employed to determine the 
anticarcinogenic and anticancer potential of these natural 
phenolic compounds or extracts[28].
  Taken together our results suggests that the fractions of 
extracts obtained in from TP and FR have good cytotoxic 
activity against human breast cancer cell line i.e. MCF-7 
which may be attributed to the flavonoids and phenolic 
constituents of the fractions. 
Vishal Gulecha et al./Asian Pacific Journal of Tropical Medicine (2011)526-529 529
Conflict of interest statement
  We declare that we have no conflict of interest.
Acknowledgments
  Authors are thankful to Dr. Nitin Desai, Dean, Faculty of 
Sciences, Dr. DY Patil Deemed University, Sector15, CBD 
Belapur, Navi Mumbai for providing necessary facilities.
 
References   
          
[1]   Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG 
inhibits growth, invasion, angiogenesis and metastasisof pancreatic 
cancer. Frontiers in Biosci 2008; 13(2): 440-452. 
[2]   Ravindranath MH, Ramasamy V, Moon S, Ruiz C , Muthugounder 
S. Differential growth suppression of human melanoma cells by 
tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG),” 
E-CAM 2009; 6: 523-530. 
[3]   Huang HP, Shih YW, Chang YC, Hung CN, Wang CJ. 
Chemoinhibitory effect of mulberry anthocyaninson melanoma 
metastasis involved in the Ras/PI3K pathway. J Agri Food Chem 
2008; 56(19): 9286-9293. 
[4]   Chen PN, Hsieh YS, Chiou HL, Chu SC. Silibinin inhibits cell 
invasion through inactivation of both PI3K-Akt and MAPK 
signaling pathways. Chemico Biological Interactions 2005; 156(2-
3):141-150. 
[5]   Vieira JRC, De Souza IA, Do Nascimento SC, Leite SP. Indigofera 
suffruticosa: an alternative anticancertherapy. E-CAM 2007; 4(3): 
355-359. 
[6]   Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal 
plants. New Delhi: Council of Scientific and Industrial Research; 
1956.
[7]   Kirtikar KR, Basu BD. Indian medicinal plants. 2nd ed. 
Allahabad: Lalit Mohan Basu;1956.  
[8]   Rahman H, Kashifudduja M, Syed M, Saleemuddin M. 
Hypoglycemicactivity of Tephrosia purpurea seeds. Indian J Med 
Res 1985; 81: 418.
[9]   Gokhale AB,  Saraf  MN.  Tephrosia purpurea: a review of 
contemporary literature and medicinal properties. Indian Drugs 
2000; 37: 553-560
[10] Murthy MSR, Srinivasan M. Hepatoprotective effect of Tephrosia 
purpurea in experimental animals. Indian J Pharmacol 1993; 
25:34-36.
[11] Gokhale AB, Dikshit VJ, Damle AS, Kulkarni KR, Saraf MN. 
Influence of ethanolic extract of Tephrosia purpurea Linn. on mast 
cells and erythrocytes membrane integrity. Indian J Exp Biol 
2000; 38: 837-840.
[12] Pelter A, Ward  RS,  Rao EV,  Raju NR. 8-Substituted flavonoids 
and 3-substituted 7-oxygenated chalcones from Tephrosia 
purpurea. J Chem Society 1981; 1: 2491.
[13] Ripu MK, Rainer WB. Ficus (Fig) species in Nepal: a review of 
diversity and indigenous uses. Lyonia 2006; 11: 85-97.
[14] Vyawahare NS, Khandelwal AR, Batra VR, Nikam AP. Herbal 
anticonvulsants. J Herbal Med Toxicol 2007; 1: 9-14.
[15] Vinutha B, Prashanth D, Salma K, Sreeja SL, Pratiti D, Padmaja 
R, et al. Screening of selected Indian medicinal plants for 
acetylcholinesterase inhibitory activity. J Ethnopharmacol  2007; 
109: 359-363.
[16] RatnasooriyaWD, Jayakody JR, Dharmasiri AC. An aqueous 
extract of trunk bark of Ficus religiosa has anxiolytic activity. Med 
Sci Res 1998; 26: 817-819.
[17] Bliebtrau JN. The parable of the beast. New York: Macmillan 
Company;1998,p.74.
[18] Mehrotra BN, Rastogi RD. Compendium of Indian medicinal 
plants. New Delhi: Central Drug Research Institute, Lucknow 
and National Institute of Science Communication and Information 
Resources; 2004, P.188. 
[19] Nadkarni KM. Indian materia medica. 3rd ed. Bombay: Popular 
Prakashan Private Limited; 1976, p. 552. 
[20] Swami KD. Bisht NPS. Constituents of Ficus religiosaand F. 
infectoria and their biological activity. J Indian Chem Soc 1996; 
73: 631.
[21] Senthilkumar R, Manivannan R, Balasubramaniam A, Sivakumar 
T, Rajkapoor B. Effects of ethanol extract of Pisonia aculeate Linn. 
on ehrlich ascites carcinoma tumour bearing mice. Int J Green 
Pharm 2008; 2(1): 50-53.
[22] Bar tek  J ,  Iggo  R,  Gannon J ,  Lane  DP.  Genet ic  and 
immunochemical analysis of mutant p53 in human breast cancer 
cell lines. Oncogene 1990; 5:893-899.
[23] Brown JP. A review of the genetic effect of naturally occurring 
flavonoids, anthraquinones and related compounds. Mutat Res 
1980; 75: 243-247. 
[24] Hirano TK, Oka M, Akiba M. Antiproliferative effect of synthetic 
and naturally occurring flavonoids on tumour cells of human 
breast carcinoma cell lines, ZR-75-1. Res Commun Chem Pathol 
Pharmacol 1989; 64: 69-78.
[25] Weber G, Shen F, Prajda N, Yeh YA, Yang H. Increased signal 
transduction activity and down regulation in human cancer cells. 
Anticancer Res 1996; 16: 3271-3282. 
[26] Osman MA, Rashid MM, Aziz MA, Habib MR, Karim MR. 
Inhibition of Ehrlich ascites carcinoma by Manilkara zapota L. 
stem bark in Swiss albino mice. Asian Pac J Trop Biomed 2011; 
1(6): 448-451.
[27] Fotis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H. 
Flavonoids, dietary-derived inhibitors of cell proliferation and in 
vitro angiogenesis. Cancer Res 1997; 57: 2916-2921. 
[28] Dai Jin, Mumper RJ. Plant phenolics: extraction, analysis and 
their antioxidant and anticancer properties. Molecules 2010; 15: 
7313-7352.
